Penn State Well being on Wednesday unveiled a brand new robot-assisted bronchoscopy system that it says can detect lung most cancers at its earliest phases.
The Monarch Platform, which was developed by Auris Well being, is the primary industrial robotic platform for therapeutic and diagnostic bronchoscopy procedures and is accessible at Penn State Well being Hampden Medical Heart.
The well being system stated this expertise permits physicians to diagnose small peripheral lung nodules which can be sometimes onerous to achieve by means of common bronchoscopy. Having the ability to entry and diagnose these lung nodules will assist physicians carry out earlier biopsies to diagnose and deal with lung most cancers sooner.
“Lung most cancers is the main explanation for most cancers deaths worldwide. Greater than 80% of individuals with superior lung most cancers don’t survive 5 years after prognosis,” stated Dr. Chris Shaffer, a pulmonologist at Hampden Medical Heart. “The stage at prognosis is the important thing to raised outcomes — the vast majority of individuals identified with early stage lung most cancers do survive. With this expertise, we’ll detect early indicators of lung most cancers and get critically wanted therapy a lot sooner. It is a sport changer.”
Persons are additionally studying…
The Monarch Platform combines conventional digital camera views contained in the lung with computer-assisted navigation based mostly on 3-D fashions of the affected person’s lung anatomy. Pulmonologists at Hampden Medical Heart started utilizing the platform for the minimally invasive process in mid-Could.
“We stay up for implementing this technique to boost doctor capabilities and, extra importantly, enhance affected person outcomes,” Shaffer stated.
E-mail Naomi Creason at [email protected] or observe her on Twitter @SentinelCreason.
